Current Status of Treg Therapy in Transplantation and Autoimmune Disease

The authors review preclinical and clinical applications of Treg-based therapies, including adoptive Treg transfer, low-dose IL-2, and CAR-Treg therapy. They discuss their effectiveness in modulating immune responses across diverse pathological contexts.